ULg receives WHO prequalifaction for drug control

December 19, 2016 News BioVox

After being the first European university to receive the GMP (Good Manufacturing Practices) certification for the quality control of drugs in 2014, ULg is now also the first university in the world to be prequalified by the WHO (World Health Organization). 

The ULg thus becomes an official partner of the WHO, the United Nations and the Member States. From now on, the WHO can entrust the ULg with testing and quality control of the production of medicines of manufacturers, all over the world.

The WHO prequalification also enables the ULg to strengthen its services to national quality control laboratories in developing countries, thus contributing to the improvement of health systems in these countries by providing them with technical assistance, best practices (ISO, GMP …) and the training of the personnel of the pharmaceutical and control laboratories.

At the request of the WHO, the ULg is pursuing this mission more specifically in four African countries: the DR Congo, Burkina Faso, Benin and Rwanda. In addition, ULg is co-financed in Belgium by ARES for the organization of international training courses on the quality of medicines: it can now offer a WHO-labeled framework for trainees, particularly from Africa.

As a reference laboratory, ULg now has the opportunity to access major international surveys by the WHO, for example on HIV / AIDS, Anti-Malaria or Lifesaving Commodities. Together with the other prequalified laboratories, the ULg participates in a global network of excellence,  exchanging information and good practices, particularly in the international fight against the falsification of medicines.

It is at the end of a sharp audit guaranteeing strict compliance with the most demanding international standards that the ULg has been awarded the WHO prequalification. This label shall be re-evaluated at least every three years.
Ultimately, the heads of the Department of Pharmacy hope to become a WHO Collaborative Center, which would be the highest international recognition of the ULg’s skills for quality control of the drug.

You might also like: 
Watch Liège becoming a major healthcare hub

Avatar photo

With a local focus and global reach, the news platform BioVox shares insights into the Benelux life sciences ecosystem with readers across the world. BioVox is an independent publisher, providing its community with quality content and first-row access to interesting breakthroughs and trends in biotech, medtech, agtech, pharma, and more. We shine a spotlight on the latest news and innovations from both our partners and community.

All posts

Subscribe to the BioVox newsletter